Two Sigma Investments, LP Milestone Pharmaceuticals Inc. Transaction History

Two Sigma Investments, LP

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 14, 2023	BUY	$2.85 - $4.4 $48,105 - $74,267	16,879 Added 47.81%	52,186 $148,000
Q1 2023 May 15, 2023	SELL	$3.14 - $4.2 $499,373 - $667,951	-159,036 Reduced 81.83%	35,307 $139,000
Q4 2022 Feb 14, 2023	BUY	$3.53 - $9.5 $686,030 - $1.85 Million	194,343 New	194,343 $769,000
Q3 2021 Nov 15, 2021	SELL	$5.28 - $6.29 $85,720 - $102,118	-16,235 Closed	0 $0
Q2 2021 Aug 16, 2021	SELL	$5.22 - $6.11 $201,377 - $235,711	-38,578 Reduced 70.38%	16,235 $89,000
Q1 2021 May 17, 2021	SELL	$5.79 - $8.85 $15,042 - $22,992	-2,598 Reduced 4.53%	54,813 $317,000
Q4 2020 Feb 16, 2021	BUY	$5.57 - $7.66 $208,925 - $287,318	37,509 Added 188.47%	57,411 $385,000
Q3 2020 Nov 16, 2020	BUY	$3.34 - $9.8 $66,472 - $195,039	19,902 New	19,902 $146,000

28.7M

200

Ticker MIST
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 30,010,900
Market Cap $67.5M
Description
Milestone Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of cardiovascular medicines. The company is developing etripamil, a novel channel blocker, which is in Phase III clinical trial for the treatment of paroxysmal supraventricular tachycardia in the United States and Canada; and Phase II cl...

Get notified when there are updates to the investment portfolio of Two Sigma Investments, LP, based on Form 13F filings with the SEC.

Stay updated on Two Sigma Investments, LP with notifications on news.